A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung Cancer
Study Number: 

PH 290316

Phase: 
2
Principal Investigator: 
Grace Dy, MD

Check your eligibility for this trial.

Official Title: 
A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Subjects with Advanced Non-small Cell Lung Cancer (FRACTION-Lung)
Purpose: 
The purpose of this study is to determine whether nivolumab in combination with other therapies is more effective than nivolumab alone in people with advanced lung cancer.
ClinicalTrials.Gov ID: 
NCT02750514
Learn more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-877-ROSWELL (1-877-767-9355) or e-mail askroswell@roswellpark.org.